Boston Biomedical Gets $2M


Boston Biomedical, a Norwood, MA-based biotech startup focused on cancer drugs, has raised $2 million in equity financing, according to an SEC filing. Li Chiang, the CEO and founder of Boston Biomedical, was not immediately available for comment this afternoon. It’s unclear who invested in the round. The company in April issued a press release that said it was developing a drug that targeted stem-like properties of certain cancer cells.

By posting a comment, you agree to our terms and conditions.